ANTI-ETANERCEPT ANTIBODIES AND ETANERCEPT LEVES LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW AND FULL-DOSE ETANERCEPT IN DAS28 REMISSION

被引:0
|
作者
Ometto, F. [1 ]
Beggio, M. [1 ]
Friso, L. [1 ]
Astorri, D. [1 ]
Raffeiner, B. [1 ,2 ]
Botsios, C. [1 ]
Bernardi, L. [1 ]
Padoan, R. [1 ]
Punzi, L. [1 ]
机构
[1] Univ Padua, Med Dept DIMED, Rheumatol Unit, Padua, Italy
[2] Gen Hosp Bolzano, Internal Med, Rheumatol Unit, Bolzano, Italy
关键词
D O I
10.1136/annrheumdis-2016-eular.5841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0178
引用
收藏
页码:494 / 494
页数:1
相关论文
共 50 条
  • [1] Clinical Relevance of Etanercept Levels and Anti-Etanercept Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients
    Drynda, Susanne
    Kekow, Joern
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] DIFFERENT STRATEGIES OF LOW DOSE ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION
    Bernardi, L.
    Ornetto, F.
    Botsios, K.
    Punzi, L.
    Raffeiner, B.
    Doria, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1036 - 1036
  • [3] YOUNG RHEUMATOID ARTHRITIS PATIENTS ARE MORE LIKELY TO BE IN SDAI OR DAS28 REMISSION IN COMPARISON TO OLDER PATIENTS AFTER ONE YEAR OF TREATMENT WITH ADALIMUMAB OR ETANERCEPT
    l'Ami, M.
    Krieckaert, C.
    Kneepkens, E.
    Plasencia, C.
    Nurmohamed, M.
    Wolbink, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 475 - 476
  • [4] Effects of low-dose etanercept in maintaining DAS-remission previously achieved with standard-dose in patients with rheumatoid arthritis
    Botsios, C.
    Furlan, A.
    Ostuni, R.
    Sfriso, R.
    Todesco, S.
    Punzi, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 54 - 54
  • [5] ACHIEVEMENT AND MAINTENANCE OF REMISSION/LOW DISEASE ACTIVITY OVER 24 MONTHS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT OR ETANERCEPT plus METHOTREXATE IN THE CANADIAN METHOTREXATE AND ETANERCEPT OUTCOME (CAMEO) STUDY
    Pope, J. E.
    Haraoui, B.
    Thorne, J. C.
    Phan-Chronis, K.
    Poulin-Costello, M.
    Vieira, A.
    Keystone, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 240 - 240
  • [6] Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
    Iwamoto, Naoki
    Kawakami, Atsushi
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Kawashiri, Shin-ya
    Tamai, Mami
    Arima, Kazuhiko
    Ichinose, Kunihiro
    Kamachi, Makoto
    Yamasaki, Satoshi
    Nakamura, Hideki
    Nakashima, Munetoshi
    Mizokami, Akinari
    Goto, Akiko
    Fukuda, Takaaki
    Matsuoka, Naoki
    Ueki, Yukitaka
    Tsukada, Toshiaki
    Migita, Kiyoshi
    Shoumura, Fumiko
    Kawabe, Yojiro
    Shibatomi, Kazutaka
    Mine, Masanobu
    Ida, Hiroaki
    Origuchi, Tomoki
    Aoyagi, Kiyoshi
    Eguchi, Katsumi
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (05) : 488 - 492
  • [7] Low and transient auto- and anti-etanercept antibody formation has no measurable impact on clinical outcomes during 5 years of etanercept (ENBREL) treatment in patients with rheumatoid arthritis
    Klareskog, L.
    Wajdula, J.
    Baker, P.
    Fatenejad, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 325 - 326
  • [8] Diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with etanercept
    Drynda, S.
    Wollenberg, H.
    Khne, C.
    Polter, J.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A21 - A22
  • [9] Association of anti-CCP antibodies and YKL-40 levels with radiographic outcome of etanercept treated patients with rheumatoid arthritis
    Drynda, S.
    Rossbach, A-K.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A54 - A54
  • [10] Relationships Between DAS28 Response and Clinical, Functional and Radiographic Outcomes in Year 2 of the COMET Study of Etanercept in Patients with Rheumatoid Arthritis
    Emery, Paul
    Breedveld, Ferdinand
    Pedersen, Ronald
    Campos, Eduardo Jose
    Szumski, Annette
    Hirose, Tomohiro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71